In a similar study performed on skin samples from healthy subjects and atopic dermatitis patients, a biotin-556 tracer was injected into skin biopsies and the paracellular permeability was measured by counting the regions where the tracer colocalized with claudin-1 fluorescence (“tracer stops”). This evidence concerns the gene CLDN1 and atopic eczema.